The Statewide Renal Clinical Network (SReCN) focuses on clinical practice improvement and quality and safety enhancements, and provides expertise, direction, and advice on evidence based best practice to Queensland Health clinicians caring for renal patients.
The steering committee membership is multidisciplinary and includes Queensland clinicians with an interest in renal health. It provides expertise, direction and advice to healthcare administrators and planners, the Department of Health and government, as well as leadership and guidance to key clinical streams and their advisory groups.
The steering committee is co-chaired by:
- Professor Keshwar Baboolal, Consultant Nephrologist and Executive Director, Internal Medicine Services, Royal Brisbane and Women’s Hospital, Metro North Hospital and Health Service
- Dr Sree Krishna Venuthurupalli, Senior Consultant Nephrologist, Toowoomba Hospital, Darling Downs Hospital and Health Service.
The role of the network
- improve the quality, safety, and effectiveness of renal care in Queensland
- provide expertise, direction and advice to the Queensland Health Executive and Hospital and Health Services and Boards in relation to renal service planning; and emerging issues locally, statewide and nationally
- provide expertise, direction and advice and develop an open and supportive environment for clinicians who are involved in caring for patients, and consumers of renal services in Queensland
- foster education and research in renal best practice.
The SReCN is progressing priorities through working groups, subcommittees and special interest groups.
Renal Pharmacist Special Interest Group
The Renal Pharmacist Special Interest Group was established to engage pharmacist’s working within renal dialysis units, outpatient and in-patient settings within Queensland to allow greater sharing of common interests, problems and protocols.
Heparin-induced Thrombocytopenia (HiTs) Guideline Working Group
The Heparin-induced Thrombocytopaenia (HiT) Guideline Working Group was established to review and update the Anticoagulation in haemodialysis patients with HiT guideline. This process is being undertaken to ensure the guideline aligns with current best practice evidence and thereby supports clinicians with tools to assist in the delivery of standardised evidence-based management of haemodialysis patients.
Kidney Foot Disease Working Group
The Kidney Foot Disease (KFD) Working Group was established for the purpose of:
- developing clinical consensus on best practice foot care for patients with kidney disease
- developing a statewide foot screening tool for chronic kidney disease/end stage kidney disease
- implementing strategies to improve awareness of KFD complications and referral services amongst clinicians and patients.
Dialysis Access Referral Form Working Group
The Dialysis Access Referral Form Working Group will review and update the referral form.
- Support the development and implementation of the Advancing Kidney Care 2026 Plan.
- Develop clinical guidelines, pathways and resources to support evidence based practice in renal services.
- Advance training and education in nephrology and renal transplant throughout Queensland.
- Support clinical projects and research related to renal patients and service delivery.
These communiques provide updates on the work of the network and their recent achievements.
- Edition 9: December 2020
- Edition 8: June 2020
- Edition 7: December 2019
- Edition 6: October 2019
- Edition 5: April 2019
- Edition 4: December 2018
- Edition 3: August 2018
- Edition 2: November 2017
Phone: +61 7 3328 9124
Postal Address: GPO Box 48, Brisbane 4001